{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T06:14:33Z","timestamp":1778739273452,"version":"3.51.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T00:00:00Z","timestamp":1757462400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T00:00:00Z","timestamp":1757462400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s00428-025-04255-7","type":"journal-article","created":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T19:53:10Z","timestamp":1757533990000},"page":"1077-1086","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Inflammatory gene expression profile of oral plasmablastic lymphoma"],"prefix":"10.1007","volume":"488","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6182-9232","authenticated-orcid":false,"given":"Roberta Rayra","family":"Martins-Chaves","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4212-1172","authenticated-orcid":false,"given":"Marina Gon\u00e7alves","family":"Diniz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda Faria","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9032-2067","authenticated-orcid":false,"given":"Cinthia Veronica Bard\u00e1lez L\u00f3pez","family":"de C\u00e1ceres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1840-4911","authenticated-orcid":false,"given":"Pablo Agustin","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3259-606X","authenticated-orcid":false,"given":"Bruno Augusto Benevenuto","family":"de Andrade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8704-5994","authenticated-orcid":false,"given":"Aline Ara\u00fajo","family":"Sampaio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5152-1277","authenticated-orcid":false,"given":"Nicolau Conte","family":"Neto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7609-8804","authenticated-orcid":false,"given":"H\u00e9lder Ant\u00f4nio Rebelo","family":"Pontes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3207-4007","authenticated-orcid":false,"given":"Ricardo Alves","family":"Mesquita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6861-6640","authenticated-orcid":false,"given":"Ciro Dantas","family":"Soares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7644-4159","authenticated-orcid":false,"given":"Guilherme Rossi Assis","family":"de Mendon\u00e7a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8770-8009","authenticated-orcid":false,"given":"Ricardo Santiago","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6657-4547","authenticated-orcid":false,"given":"Felipe Paiva","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,10]]},"reference":[{"key":"4255_CR1","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s00428-019-02543-7","volume":"474","author":"J Cabe\u00e7adas","year":"2019","unstructured":"Cabe\u00e7adas J, Martinez D, Andreasen S et al (2019) Lymphomas of the head and neck region: an update. Virchows Arch 474:649\u2013665. https:\/\/doi.org\/10.1007\/s00428-019-02543-7","journal-title":"Virchows Arch"},{"key":"4255_CR2","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1182\/blood.V89.4.1413","volume":"89","author":"HJ Delecluse","year":"1997","unstructured":"Delecluse HJ, Anagnostopoulos I, Dallenbach F et al (1997) Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection. Blood 89:1413\u20131420. https:\/\/doi.org\/10.1182\/blood.V89.4.1413","journal-title":"Blood"},{"key":"4255_CR3","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1111\/jop.13211","volume":"50","author":"JAA de Arruda","year":"2021","unstructured":"de Arruda JAA, Schuch LF, Conte Neto N et al (2021) Oral and oropharyngeal lymphomas: a multi-institutional collaborative study. J Oral Pathol Med 50:603\u2013612. https:\/\/doi.org\/10.1111\/jop.13211","journal-title":"J Oral Pathol Med"},{"issue":"8","key":"4255_CR4","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1002\/ajh.27376","volume":"99","author":"A Ramirez-Gamero","year":"2024","unstructured":"Ramirez-Gamero A, Mart\u00ednez-Cordero H, Beltr\u00e1n BE et al (2024) Plasmablastic lymphoma: 2024 update on diagnosis, risk stratification, and management. Am J Hematol 99(8):1586\u20131594. https:\/\/doi.org\/10.1002\/ajh.27376","journal-title":"Am J Hematol"},{"issue":"3","key":"4255_CR5","doi-asserted-by":"publisher","first-page":"e255","DOI":"10.1016\/j.clml.2020.11.025","volume":"21","author":"NF Makady","year":"2021","unstructured":"Makady NF, Ramzy D, Ghaly R et al (2021) The emerging treatment options of plasmablastic lymphoma: analysis of 173 individual patient outcomes. Clin Lymphoma Myeloma Leuk 21(3):e255\u2013e263. https:\/\/doi.org\/10.1016\/j.clml.2020.11.025","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"4255_CR6","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.3324\/haematol.2020.251579","volume":"106","author":"J Garcia-Reyero","year":"2021","unstructured":"Garcia-Reyero J, Magunacelaya NM, de Villambrosia SG et al (2021) Genetic lesions in MYC and STAT3 drive oncogenic transcription factor overexpression in plasmablastic lymphoma. Haematologica 106:1120\u20131128. https:\/\/doi.org\/10.3324\/haematol.2020.251579","journal-title":"Haematologica"},{"issue":"11","key":"4255_CR7","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1097\/PAS.0b013e3181f3e29f","volume":"34","author":"A Valera","year":"2010","unstructured":"Valera A, Balagu\u00e9 O, Colomo L et al (2010) IG\/MYC rearrangements are the main cytogenetic alteration in plasmablastic lymphomas. Am J Surg Pathol 34(11):1686\u20131694. https:\/\/doi.org\/10.1097\/PAS.0b013e3181f3e29f","journal-title":"Am J Surg Pathol"},{"key":"4255_CR8","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/his.13959","volume":"76","author":"L Miao","year":"2020","unstructured":"Miao L, Guo N, Feng Y et al (2020) High incidence of MYC rearrangement in human immunodeficiency virus-positive plasmablastic lymphoma. Histopathology 76:201\u2013211. https:\/\/doi.org\/10.1111\/his.13959","journal-title":"Histopathology"},{"key":"4255_CR9","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/modpathol.2016.162","volume":"30","author":"S Montes-Moreno","year":"2017","unstructured":"Montes-Moreno S, Martinez-Magunacelaya N, Zecchini-Barrese T et al (2017) Plasmablastic lymphoma phenotype is determined by genetic alterations in MYC and PRDM1. Mod Pathol 30:85\u201394. https:\/\/doi.org\/10.1038\/modpathol.2016.162","journal-title":"Mod Pathol"},{"key":"4255_CR10","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1080\/10428194.2021.1986218","volume":"63","author":"A Ramburan","year":"2022","unstructured":"Ramburan A, Kriel R, Govender D (2022) Plasmablastic lymphomas show restricted EBV latency profile and MYC gene aberrations. Leuk Lymphoma 63:370\u2013376. https:\/\/doi.org\/10.1080\/10428194.2021.1986218","journal-title":"Leuk Lymphoma"},{"key":"4255_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2023.110888","author":"Y Li","year":"2023","unstructured":"Li Y, Maimaiti M, Yang B et al (2023) Comprehensive analysis of subtypes and risk model based on complement system associated genes in ccRCC. Cell Signal. https:\/\/doi.org\/10.1016\/j.cellsig.2023.110888","journal-title":"Cell Signal"},{"key":"4255_CR12","doi-asserted-by":"publisher","unstructured":"Fridman WH, Pag\u00e8s F, Saut\u0300s-Fridman C, Galon J (2012) The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer 12:298\u2013306.https:\/\/doi.org\/10.1038\/nrc3245","DOI":"10.1038\/nrc3245"},{"key":"4255_CR13","doi-asserted-by":"publisher","first-page":"11553","DOI":"10.1007\/s13277-016-5098-7","volume":"37","author":"N Kumari","year":"2016","unstructured":"Kumari N, Dwarakanath BS, Das A, Bhatt AN (2016) Role of interleukin-6 in cancer progression and therapeutic resistance. Tumor Biol 37:11553\u201311572. https:\/\/doi.org\/10.1007\/s13277-016-5098-7","journal-title":"Tumor Biol"},{"key":"4255_CR14","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.molmed.2008.03.001","volume":"14","author":"N Novak","year":"2008","unstructured":"Novak N, Haberstok J, Bieber T, Allam JP (2008) The immune privilege of the oral mucosa. Trends Mol Med 14:191\u2013198. https:\/\/doi.org\/10.1016\/j.molmed.2008.03.001","journal-title":"Trends Mol Med"},{"key":"4255_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222212149","volume":"22","author":"HF Pelaez-Prestel","year":"2021","unstructured":"Pelaez-Prestel HF, Sanchez-Trincado JL, Lafuente EM, Reche PA (2021) Immune tolerance in the oral mucosa. Int J Mol Sci 22:12149. https:\/\/doi.org\/10.3390\/ijms222212149","journal-title":"Int J Mol Sci"},{"issue":"2","key":"4255_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23020882","volume":"23","author":"M Ptasiewicz","year":"2022","unstructured":"Ptasiewicz M, Grywalska E, Mertowska P et al (2022) Armed to the teeth - the oral mucosa immunity system and microbiota. Int J Mol Sci 23(2):882. https:\/\/doi.org\/10.3390\/ijms23020882","journal-title":"Int J Mol Sci"},{"key":"4255_CR17","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1309\/AJCPJH6KEUSECQLU","volume":"134","author":"D Hansra","year":"2010","unstructured":"Hansra D, Montague N, Stefanovic A et al (2010) Oral and extraoral plasmablastic lymphoma: similarities and differences in clinicopathologic characteristics. Am J Clin Pathol 134:710\u2013719. https:\/\/doi.org\/10.1309\/AJCPJH6KEUSECQLU","journal-title":"Am J Clin Pathol"},{"key":"4255_CR18","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/jop.13269","volume":"51","author":"S Meer","year":"2022","unstructured":"Meer S, Perner Y, Willem P (2022) Oral versus extra-oral plasmablastic lymphoma: a comparative analysis of 101 cases. J Oral Pathol Med 51:146\u2013151. https:\/\/doi.org\/10.1111\/jop.13269","journal-title":"J Oral Pathol Med"},{"key":"4255_CR19","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1309\/AJCPOEOXRYIXQZ0F","volume":"135","author":"X Qing","year":"2011","unstructured":"Qing X, Sun N, French SW, Yue C (2011) Oral and extraoral plasmablastic lymphoma: similarities and differences in clinicopathologic characteristics. Am J Clin Pathol 135:977\u2013978. https:\/\/doi.org\/10.1309\/AJCPOEOXRYIXQZ0F","journal-title":"Am J Clin Pathol"},{"key":"4255_CR20","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1182\/blood.2022015851","volume":"140","author":"E Campo","year":"2022","unstructured":"Campo E, Jaffe ES, Cook JR et al (2022) The international consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee. Blood 140:1229\u20131253. https:\/\/doi.org\/10.1182\/blood.2022015851","journal-title":"Blood"},{"key":"4255_CR21","unstructured":"WHO Classification of Tumours Editorial Board (2024) Haematolymphoid tumours. International Agency for Research on Cancer, Lyon. (WHO classification of tumours series, 5th ed.; vol 11). Available from: https:\/\/publications.iarc.who.int\/637. Accessed 10 Apr 2025"},{"key":"4255_CR22","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","volume":"103","author":"CP Hans","year":"2004","unstructured":"Hans CP, Weisenburger DD, Greiner TC et al (2004) Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 103:275\u2013282. https:\/\/doi.org\/10.1182\/blood-2003-05-1545","journal-title":"Blood"},{"key":"4255_CR23","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.oooo.2020.11.005","volume":"131","author":"CI Rodrigues-Fernandes","year":"2021","unstructured":"Rodrigues-Fernandes CI, Junior AG, Soares CD et al (2021) Oral and oropharyngeal diffuse large B-cell lymphoma and high-grade B-cell lymphoma: a clinicopathologic and prognostic study of 69 cases. Oral Surg Oral Med Oral Pathol Oral Radiol 131:452-462.e4. https:\/\/doi.org\/10.1016\/j.oooo.2020.11.005","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"4255_CR24","doi-asserted-by":"publisher","first-page":"W207","DOI":"10.1093\/nar\/gkad347","volume":"51","author":"L Kolberg","year":"2023","unstructured":"Kolberg L, Raudvere U, Kuzmin I et al (2023) G:profiler-interoperable web service for functional enrichment analysis and gene identifier mapping (2023 update). Nucleic Acids Res 51:W207\u2013W212. https:\/\/doi.org\/10.1093\/nar\/gkad347","journal-title":"Nucleic Acids Res"},{"key":"4255_CR25","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1111\/jop.13210","volume":"50","author":"FP Fonseca","year":"2021","unstructured":"Fonseca FP, Robinson L, van Heerden MB, van Heerden WFP (2021) Oral plasmablastic lymphoma: a clinicopathological study of 113 cases. J Oral Pathol Med 50:594\u2013602. https:\/\/doi.org\/10.1111\/jop.13210","journal-title":"J Oral Pathol Med"},{"key":"4255_CR26","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1111\/jop.12753","volume":"47","author":"CI Rodrigues-Fernandes","year":"2018","unstructured":"Rodrigues-Fernandes CI, de Souza LL, Santos-Costa SFD et al (2018) Clinicopathological analysis of oral plasmablastic lymphoma: a systematic review. J Oral Pathol Med 47:915\u2013922. https:\/\/doi.org\/10.1111\/jop.12753","journal-title":"J Oral Pathol Med"},{"key":"4255_CR27","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/0161-5890(86)90159-8","volume":"23","author":"R Frade","year":"1986","unstructured":"Frade R (1986) Structure and functions of GP 140, the C3d\/EBV receptor (CR2) of human B lymphocytes. Mol Immunol 23:1249\u20131253. https:\/\/doi.org\/10.1016\/0161-5890(86)90159-8","journal-title":"Mol Immunol"},{"key":"4255_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/1756-8722-2-47","volume":"2","author":"CC Chang","year":"2009","unstructured":"Chang CC, Zhou X, Taylor JJ et al (2009) Genomic profiling of plasmablastic lymphoma using array comparative genomic hybridization (aCGH): revealing significant overlapping genomic lesions with diffuse large B-cell lymphoma. J Hematol Oncol 2:47. https:\/\/doi.org\/10.1186\/1756-8722-2-47","journal-title":"J Hematol Oncol"},{"key":"4255_CR29","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1038\/leu.2015.109","volume":"29","author":"J Chapman","year":"2015","unstructured":"Chapman J, Gentles AJ, Sujoy V et al (2015) Gene expression analysis of plasmablastic lymphoma identifies downregulation of B-cell receptor signaling and additional unique transcriptional programs. Leukemia 29:2270\u20132273","journal-title":"Leukemia"},{"key":"4255_CR30","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1182\/bloodadvances.2021005486","volume":"6","author":"HM Witte","year":"2022","unstructured":"Witte HM, Kunstner A, Hertel N et al (2022) Integrative genomic and transcriptomic analysis in plasmablastic lymphoma identifies disruption of key regulatory pathways. Blood Adv 6:637\u2013651. https:\/\/doi.org\/10.1182\/bloodadvances.2021005486","journal-title":"Blood Adv"},{"issue":"4","key":"4255_CR31","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.pathol.2020.03.004","volume":"52","author":"MH Huang","year":"2020","unstructured":"Huang MH, Chen BJ, Chang ST et al (2020) Double-hit plasmablastic lymphoma with malignant pleural effusion and leukaemic presentation. Pathology 52(4):488\u2013491. https:\/\/doi.org\/10.1016\/j.pathol.2020.03.004","journal-title":"Pathology"},{"issue":"8","key":"4255_CR32","doi-asserted-by":"publisher","first-page":"976","DOI":"10.3324\/haematol.2016.141978","volume":"101","author":"C Laurent","year":"2016","unstructured":"Laurent C, Fabiani B, Do C et al (2016) Immune-checkpoint expression in Epstein-Barr virus positive and negative plasmablastic lymphoma: a clinical and pathological study in 82 patients. Haematologica 101(8):976\u2013984. https:\/\/doi.org\/10.3324\/haematol.2016.141978","journal-title":"Haematologica"},{"key":"4255_CR33","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.oraloncology.2011.06.506","volume":"47","author":"SC Boy","year":"2011","unstructured":"Boy SC, van Heerden MB, Babb C et al (2011) Dominant genetic aberrations and coexistent EBV infection in HIV-related oral plasmablastic lymphomas. Oral Oncol 47:883\u2013887. https:\/\/doi.org\/10.1016\/j.oraloncology.2011.06.506","journal-title":"Oral Oncol"},{"key":"4255_CR34","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1309\/AJCPWY1SGJ9IEAOR","volume":"134","author":"I Ouansafi","year":"2010","unstructured":"Ouansafi I, He B, Fraser C et al (2010) Transformation of follicular lymphoma to plasmablastic lymphoma with c-myc gene rearrangement. Am J Clin Pathol 134:972\u2013981. https:\/\/doi.org\/10.1309\/AJCPWY1SGJ9IEAOR","journal-title":"Am J Clin Pathol"},{"key":"4255_CR35","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3960\/jslrt.18003","volume":"58","author":"M Ise","year":"2018","unstructured":"Ise M, Kageyama H, Ikebe D et al (2018) Transformation of double-hit follicular lymphoma to plasmablastic lymphoma: a partial role of MYC gene rearrangement. J Clin Exp Hematop 58:128\u2013135. https:\/\/doi.org\/10.3960\/jslrt.18003","journal-title":"J Clin Exp Hematop"},{"key":"4255_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.795330","volume":"11","author":"H Liu","year":"2021","unstructured":"Liu H, Shen Q, Chang CC, Hu S (2021) Phenotypic switch in high-grade B-cell lymphoma with MYC and BCL6 rearrangements: a potential mechanism of therapeutic resistance in lymphoma? Front Oncol 11:795330. https:\/\/doi.org\/10.3389\/fonc.2021.795330","journal-title":"Front Oncol"},{"key":"4255_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2023.155059","volume":"253","author":"BJ Chen","year":"2024","unstructured":"Chen BJ, Hsieh TH, Yuan CT et al (2024) Clinicopathological and genetic landscape of plasmablastic lymphoma in Taiwan. Pathol Res Pract 253:155059. https:\/\/doi.org\/10.1016\/j.prp.2023.155059","journal-title":"Pathol Res Pract"},{"key":"4255_CR38","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1111\/bjh.17708","volume":"194","author":"JR Chapman","year":"2021","unstructured":"Chapman JR, Bouska AC, Zhang W et al (2021) EBV-positive HIV-associated diffuse large B cell lymphomas are characterized by JAK\/STAT (STAT3) pathway mutations and unique clinicopathologic features. Br J Haematol 194:870\u2013878. https:\/\/doi.org\/10.1111\/bjh.17708","journal-title":"Br J Haematol"},{"key":"4255_CR39","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1097\/PAS.0000000000001459","volume":"44","author":"Y Liu","year":"2020","unstructured":"Liu Y, Jelloul F, Zhang Y et al (2020) Genetic basis of extramedullary plasmablastic transformation of multiple myeloma. Am J Surg Pathol 44:838\u2013848. https:\/\/doi.org\/10.1097\/PAS.0000000000001459","journal-title":"Am J Surg Pathol"},{"key":"4255_CR40","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1042\/bj3530109","volume":"353","author":"D Lejeune","year":"2001","unstructured":"Lejeune D, Demoulin JB, Renauld JC (2001) Interleukin 9 induces expression of three cytokine signal inhibitors: cytokine-inducible SH2-containing protein, suppressor of cytokine signalling (SOCS)-2 and SOCS-3, but only SOCS-3 overexpression suppresses interleukin 9 signalling. Biochem J 353:109\u2013116","journal-title":"Biochem J"},{"key":"4255_CR41","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.3324\/haematol.2020.271957","volume":"106","author":"JE Ramis-Zaldivar","year":"2021","unstructured":"Ramis-Zaldivar JE, Gonzalez-Farre B, Nicolae A et al (2021) MAPK and JAK-STAT pathways dysregulation in plasmablastic lymphoma. Haematologica 106:2682\u20132693. https:\/\/doi.org\/10.3324\/haematol.2020.271957","journal-title":"Haematologica"},{"key":"4255_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-015-1778-8","author":"GG Vega","year":"2015","unstructured":"Vega GG, Avil\u00e9s-Salas A, Chalapud JR et al (2015) P38 MAPK expression and activation predicts failure of response to CHOP in patients with diffuse large B-cell lymphoma. BMC Cancer. https:\/\/doi.org\/10.1186\/s12885-015-1778-8","journal-title":"BMC Cancer"},{"key":"4255_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.modpat.2023.100198","author":"A Mansoor","year":"2023","unstructured":"Mansoor A, Kamran H, Akhter A et al (2023) Identification of potential therapeutic targets for plasmablastic lymphoma through gene expression analysis: insights into RAS and Wnt signaling pathways. Mod Pathol. https:\/\/doi.org\/10.1016\/j.modpat.2023.100198","journal-title":"Mod Pathol"},{"key":"4255_CR44","doi-asserted-by":"publisher","unstructured":"Joseph S, Zhang X, Droby G et al (2024) MAPK14 \/p38\u03b1 shapes the molecular landscape of endometrial cancer and promotes tumorigenic characteristics. bioRxiv. https:\/\/doi.org\/10.1101\/2024.06.25.600674","DOI":"10.1101\/2024.06.25.600674"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-025-04255-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-025-04255-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-025-04255-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T05:58:48Z","timestamp":1778738328000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-025-04255-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,10]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["4255"],"URL":"https:\/\/doi.org\/10.1007\/s00428-025-04255-7","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,10]]},"assertion":[{"value":"5 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"During the preparation of this work, the authors used the writing assistance tool Grammarly (\n                      \n                      ) in order to improve readability and language. After using this tool, the authors reviewed and edited the content as needed and take full responsibility for the content of the publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of generative AI and AI-assisted technologies in the writing process"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}